Alan Potts
Alan Potts, PhD, is Director of Analytical Development, Patheon.
Articles
Approaches to USP OTC Monograph Modernization
Donna Seibert;Catherine Vicente;Alan Potts;Saul Gylys;Mike Wisser;John S. Punzi;Michael Rankin;Amy Ellefsen
December 12th 2017The authors hope to facilitate further collaboration among all the stakeholders for USP OTC Monograph Modernization with the goal of identifying a satisfactory approach for USP, FDA, and industry.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: October 28th 2024 | Updated: November 23rd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 23rd 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 23rd 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 23rd 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
